- December 15, 2001. “After Two-Decade Halt, Marijuana Research Is Set” — Philip J. Hilts, The New York Times
- December 10, 2001. “Getting the FDA Hooked on Ecstasy” — Kristen Philipkoski, Wired News
- One small correction to this article by Rick Doblin: “While Dr. George Ricaurte is exceedingly cautious about the risks of MDMA, I don’t think he really believes that MDMA is too dangerous to give to humans under any circumstances. I’m not exactly sure what his position is on the MDMA/PTSD protocol.”
- One small correction to this article by Rick Doblin: “While Dr. George Ricaurte is exceedingly cautious about the risks of MDMA, I don’t think he really believes that MDMA is too dangerous to give to humans under any circumstances. I’m not exactly sure what his position is on the MDMA/PTSD protocol.”
- December 8, 2001. “B.C.’s Acid Flashback” — R.C., Vancouver Sun
- November 30, 2001. “Criminalizing Ecstasy Drug Increases Use and Danger” — By Kevin B. Zeese, President of Common Sense for Drug Policy, as published in the Los Angeles Daily Journal.
- November 30, 2001. “Party drug could harm women more than men, study says” — Emma Ross, AP Wire Service.
- November 29, 2001. “Heavy Ecstasy Use Affects Serotonin Neurons in Women More Than in Men” — Reuters Health
- Reneman, L; Booij, K; de Bruin, K; Reitsma, JB; de Wolff, FA; Gunning, WB; den Heeten, GJ; van den Brink, W (2001) “Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons”. Lancet, 358: 1864-1869.
- Comments on the Reneman/Lancet Paper by Ilsa Jerome, Rick Doblin, George Ricaurte, Una McCann and Alex Gamma
- Reneman, L; Booij, K; de Bruin, K; Reitsma, JB; de Wolff, FA; Gunning, WB; den Heeten, GJ; van den Brink, W (2001) “Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons”. Lancet, 358: 1864-1869.
- November 27, 2001. “Author Says ‘Use Your Head’ When Experimenting with It” — Kevin Smith, Arizona Daily Wildcat. Interview with Charles Hayes, discussing responsible use of psychedelics as well as MAPS’ recently approved MDMA/PTSD study.
- November 18, 2001. “Psychedelia’s Middle-Aged Head Trip” — New York Times article discussing the FDA’s recent approval of the MAPS-sponsored MDMA/PTSD study as well as the repercussions of the 60’s psychedelic movement on later efforts to conduct psychedelic research.
All text version of article
- November 17, 2001. “FDA Reported to Approve Ecstasy for PTSD Clinical Trial” — Alcohol & Drug Abuse Weekly
- November 16, 2001. “It’s Only Prozac-Plus” — Ha’Aretz (Israel’s newspaper)
- November 11, 2001. “Ecstasy in the Lab, Legally” — New York Times Week in Review
- November 9, 2001. “Ecstasy ‘may fight traumatic stress'” — BBC News Online
- November 8, 2001. “Reconsidering MDMA” — Denver Post editorial applauding the FDA for approving MDMA/PTSD protocol.
- November 7, 2001. “Regulators Approve Study of Ecstasy for Post-Traumatic Stress” — Reuters Health
- November 7, 2001. “FDA Approves Clinical Test of Ecstasy” — AP Wire Service
- November 7, 2001. “Group Says FDA Clears Study of Ecstasy” — Lisa Richwine, Reuters Wire Service.
- November 6, 2001. “FDA Permits First Test of Ecstasy As Treatment for Stress Disorder” — Rachel Zimmerman, The Wall Street Journal.
- November 5, 2001. “The Other Side of Ecstasy” — Lisa Marshall, The Daily Camera. Discusses the therapeutic potential of MDMA, featuring Marcela Ot’alora and Rick Doblin, Ph.D.
- September 25, 2001. “For Partygoers Who Can’t Say No, Experts Try to Reduce the Risks” — Jeff Stryker, New York Times. Discusses Ecstasy harm reduction and Dancesafe.
- September 9, 2001. “Psychedelic Studies” — Thomas Becnel, Sarasota Herald-Tribune. Superb article featuring MAPS and its involvement in the Hookahville Festival near Columbus, Ohio.
- September 4, 2001. “The People’s Prozac” — Carla Spartos, Village Voice. Good article which questions the MDMA neurotoxicity scare, mentions the MAPS MDMA/PTSD project and — of course — quotes Rick Doblin.
- August 14, 2001. “A Legal Hallucinogen, at Least for Now” — Anne-Marie O’Connor, LA Times. Article about Salvia Divinorum; features an interview with Daniel Siebert (and mentions MAPS).
- August 2001. “The FDA Trip — Or How Psychedelic Research Was Revived in the 90’s” — This article is from the first issue of Thresher, a biannual magazine published by David Latimer, Executive Editor R.U. Sirius. The first issue came out August 2001 and had a series of articles on the theme of Drug Peace.
- July 16, 2001. “The Highs and Lows of Ecstasy” — Linda Marsa, LA Times. Features Rick Doblin, Ph.D., Sue Stevens and MAPS.
- July 14, 2001. “Confessions of a Middle-Aged Ecstasy Eater” — The Guardian, London. An account of a father who was introduced to MDMA by his teenage son. While MAPS does not support the wholesale endorsement of recreational use found in this account, it’s a powerful account of intergenerational bonding.
- July 11, 2001. “Doctor Ecstasy” — Creative Loafing, Charlotte, NC. Exclusive interview with Rick Doblin, Ph.D. (and his face on the cover, too!)
- July 2, 2001. “Why All the Agony Over Ecstasy?” CNN Talkback Live. Features discussion with Rick Doblin, Ph.D.
- June 17, 2001. “Tracing the Synapses of Our Spirituality — Researchers Examine Relationship Between Brain and Religion.” Shankar Vedantam, Washington Post. Discusses psychedelic research.
- May 11, 2001. Radio interview with Charles Hayes, author of Tripping, on The Big Show with Adam Paul @ eyada; mentions MAPS. (Scroll down to May 11)
- May 3, 2001. Radio interview with Rick Doblin on The Big Show with Adam Paul @ eyada. (Scroll to the bottom under ‘May 3’; Doblin interview starts at 1:12:57 into the show)
- April 28, 2001. “Group Push Ecstasy Safety” — from the AP Wire Service. Includes a mention of the talk Rick Doblin gave at Amherst College, tips from DanceSafe and some good quotes from Charlie Grob.
- April 26, 2001. “Doctor X” — superlative Rolling Stone piece about Ecstasy, MAPS and Rick Doblin by Gary Greenberg.
- April 15, 2002. These are two excellent articles from the journal Cerebrum: The Dana Forum on Brain Science, (Volume 3, Number 2: Spring 2001) both about MDMA with discussion of MAPS’ research agenda. The article by Braun is a wonderful history while the article by Kuhn is a critique.
- “Ecstasy on Trial: Seeking Insight by Prescription” – Stephen Braun (PDF only
) - “Our Dangerous Love Affair with Ecstasy” – Cynthia M. Kuhn and Wilkie A. Wilson (PDF only )
- “Ecstasy on Trial: Seeking Insight by Prescription” – Stephen Braun (PDF only
- April 10, 2001. “Polêmica no divã do autoconhecimento” (Webmaster’s seriously questionable translation: “Controversy encouched in self-knowledge”). By Tatiana Pronin, Valor Econômico (Brazil). Read the interview with Rick Doblin in English.
- April 5, 2001. “Long, Strange Trip” — an interview with Rick Doblin by Mike Miliard, Boston Phoenix.
- March 13, 2001. “Scientists Test Hallucinogens for Mental Ills,” and “This Is the Brain on Hallucinogens,” New York Times Science Section. By Sandra Blakeslee.
- March 7, 2001. Excerpts from an interview with NIDA Director Alan Leshner, Ph.D. From the Journal of American Medical Association. Leshner discusses Ecstasy and the “hype” about the supposed therapeutic potential of MDMA.
- March 6, 2001. “Ecstasy’s Dividend” — discusses the effect of MDMA on the symptoms of Parkinson’s Disease. Johnathan Margolis, The New York Times.
- February 25, 2001. A series of articles which featured in the Denver Post that mention MDMA and MAPS. These articles are evidence of a more balanced treatment of MDMA in the media and suggest that there is growing popular support for research into MDMA’s therapeutic potential.
Ecstasy: Just Say ‘Know
Healing Through MDMA
Heed Warnings, Know Dangers
A History of MDMA
Editorial: DARE to Change
- February 12, 2001. “The Bitter Pill: Is ecstasy neurotoxic? Mmmmmaybe, maybe not…” Steve Robles, San Francisco Bay Guardian. A different perspective of “The State of Ecstasy” conference held in San Francisco on February 2.
- February 10, 2001. “High Time We Cleaned Up on Drugs.” By Kelly Morris, The Lancet. Review of two books about psychdelics ensconced in a frank discussion of the need for more open-minded scientific exploration into the realm of non-pharmaceutical, “recreational” drugs. Examines and expounds upon Rick Doblin’s Ph.D. dissertation in the greater context of the psychedelic movement.
- February 9, 2001. “San Francisco Ecstasy Conference Generates Heat But Also Light.” DRCNet Editorial.
- February 7, 2001. “Who Owns Ecstasy?” Richard Elovich & Daniel Wolfe, The Village Voice.
- A short critique of mistakes in the article from Rick Doblin.
- A short critique of mistakes in the article from Rick Doblin.
- February 5, 2001. “Legal Ecstasy in Five Years?” Kristen Philipkoski, Wired.
- February 5, 2001. “The Disunited States of Ecstasy.” By Janelle Brown, Salon Magazine. Coverage of The State of Ecstasy Conference held in San Francisco on February 2, 2001.
- February 2, 2001. “Illegal Drug Ecstasy Seen as Potential Prozac Alternative.” By Ulysses Torassa, San Francisco Chronicle.
- January 21, 2001. “Experiencing Ecstasy.” By Matthew Klam, New York Times. MAPS isn’t specifically mentioned, but two MAPS-supported projects are mentioned (Spain MDMA/PTSD study and the UCLA MDMA/cancer patient study).
- January 15, 2001. “Recreational Pharmaceuticals: Finding new party drugs like K and ecstasy won’t be easy.” By John Cloud, Time Magazine. Features an interview with Rick Doblin.
- January 4, 2001. “Adventures Through Inner Space” — ‘Psychonauts’ are experimenting with strange new drugs to expand our ideas about human consciousness. By Erik Davis, Monday Magazine.
- January 2, 2001. “Not everyone sees ecstasy as a danger — Drug’s advocates call for look at its benefits” By David Abel, January 2, 2001, E1, front page weekly Health Section, Boston Globe.
- This article is remarkable in that it mentions potential benefits of MDMA and does a fairly good job of striving for balance. Some factual errors, debatable issues and loaded terminology are discussed by Rick Doblin, Ph.D., MAPS President.
- A letter to the Editor of The Boston Globe from Rick Doblin.
- This article is remarkable in that it mentions potential benefits of MDMA and does a fairly good job of striving for balance. Some factual errors, debatable issues and loaded terminology are discussed by Rick Doblin, Ph.D., MAPS President.
2001 part 1
